Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Non-Current Deferred Tax Liability (2016 - 2025)

Historic Non-Current Deferred Tax Liability for Usana Health Sciences (USNA) over the last 15 years, with Q3 2025 value amounting to $4.5 million.

  • Usana Health Sciences' Non-Current Deferred Tax Liability fell 550.03% to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year decrease of 550.03%. This contributed to the annual value of $4.1 million for FY2024, which is 8672.81% down from last year.
  • Per Usana Health Sciences' latest filing, its Non-Current Deferred Tax Liability stood at $4.5 million for Q3 2025, which was down 550.03% from $4.7 million recorded in Q2 2025.
  • In the past 5 years, Usana Health Sciences' Non-Current Deferred Tax Liability ranged from a high of $35.7 million in Q1 2022 and a low of $4.1 million during Q4 2024
  • For the 5-year period, Usana Health Sciences' Non-Current Deferred Tax Liability averaged around $10.3 million, with its median value being $5.0 million (2021).
  • Per our database at Business Quant, Usana Health Sciences' Non-Current Deferred Tax Liability surged by 19711.05% in 2022 and then plummeted by 8672.81% in 2024.
  • Over the past 5 years, Usana Health Sciences' Non-Current Deferred Tax Liability (Quarter) stood at $7.8 million in 2021, then soared by 314.94% to $32.5 million in 2022, then decreased by 5.66% to $30.7 million in 2023, then plummeted by 86.73% to $4.1 million in 2024, then increased by 9.67% to $4.5 million in 2025.
  • Its last three reported values are $4.5 million in Q3 2025, $4.7 million for Q2 2025, and $4.8 million during Q1 2025.